These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 15711991

  • 1. [Chemodenervation with botulinumtoxin in masseteric hypertrophy].
    Mischkowski RA, Siessegger M, Lazar F, Zöller JE.
    Mund Kiefer Gesichtschir; 2005 Mar; 9(2):101-8. PubMed ID: 15711991
    [Abstract] [Full Text] [Related]

  • 2. Effects of botulinum toxin type A on bilateral masseteric hypertrophy evaluated with computed tomographic measurement.
    Kim HJ, Yum KW, Lee SS, Heo MS, Seo K.
    Dermatol Surg; 2003 May; 29(5):484-9. PubMed ID: 12752515
    [Abstract] [Full Text] [Related]

  • 3. A prospective study of the effect of botulinum toxin A on masseteric muscle hypertrophy with ultrasonographic and electromyographic measurement.
    To EW, Ahuja AT, Ho WS, King WW, Wong WK, Pang PC, Hui AC.
    Br J Plast Surg; 2001 Apr; 54(3):197-200. PubMed ID: 11254408
    [Abstract] [Full Text] [Related]

  • 4. Efficacy and safety of incobotulinum toxin A in periocular rhytides and masseteric hypertrophy: side-by-side comparison with onabotulinum toxin A.
    Lee JH, Park JH, Lee SK, Han KH, Kim SD, Yoon CS, Park JY, Lee JH, Yang JM, Lee JH.
    J Dermatolog Treat; 2014 Aug; 25(4):326-30. PubMed ID: 23356833
    [Abstract] [Full Text] [Related]

  • 5. Use of botulinum toxin type A for the treatment of masseteric muscle hypertrophy.
    Arikan OK, Tan FU, Kendi T, Koc C.
    J Otolaryngol; 2006 Feb; 35(1):40-3. PubMed ID: 16527016
    [Abstract] [Full Text] [Related]

  • 6. Botulinum toxin for masseter hypertrophy.
    Al-Muharraqi MA, Fedorowicz Z, Al Bareeq J, Al Bareeq R, Nasser M.
    Cochrane Database Syst Rev; 2009 Jan 21; (1):CD007510. PubMed ID: 19160335
    [Abstract] [Full Text] [Related]

  • 7. Treatment of masseteric hypertrophy with botulinum toxin: a report of two cases.
    Baş B, Ozan B, Muğlali M, Celebi N.
    Med Oral Patol Oral Cir Bucal; 2010 Jul 01; 15(4):e649-52. PubMed ID: 20173718
    [Abstract] [Full Text] [Related]

  • 8. Effects of botulinum toxin type A on contouring of the lower face.
    Choe SW, Cho WI, Lee CK, Seo SJ.
    Dermatol Surg; 2005 May 01; 31(5):502-7; discussion 507-8. PubMed ID: 15962731
    [Abstract] [Full Text] [Related]

  • 9. The topographic anatomy of the masseteric nerve: A cadaveric study with an emphasis on the effective zone of botulinum toxin A injections in masseter.
    Kaya B, Apaydin N, Loukas M, Tubbs RS.
    J Plast Reconstr Aesthet Surg; 2014 Dec 01; 67(12):1663-8. PubMed ID: 25175271
    [Abstract] [Full Text] [Related]

  • 10. Bilateral hypertrophy of masseteric and temporalis muscles, our fifteen patients and review of literature.
    Graziano P, Dell'Aversana Orabona G, Astarita F, Ponzo LM, Nunziata R, Salzano G, Maglitto F, Solari D, Santella A, Cappabianca M, Iaconetta G, Califano L.
    Eur Rev Med Pharmacol Sci; 2016 Dec 01; 20(1):7-11. PubMed ID: 26813447
    [Abstract] [Full Text] [Related]

  • 11. The change of maximum bite force after botulinum toxin type a injection for treating masseteric hypertrophy.
    Ahn KY, Kim ST.
    Plast Reconstr Surg; 2007 Nov 01; 120(6):1662-1666. PubMed ID: 18040203
    [Abstract] [Full Text] [Related]

  • 12. The use of botulinum toxin type A in aesthetic mandibular contouring.
    Kim NH, Chung JH, Park RH, Park JB.
    Plast Reconstr Surg; 2005 Mar 01; 115(3):919-30. PubMed ID: 15731696
    [Abstract] [Full Text] [Related]

  • 13. Evaluation and selecting indications for the treatment of improving facial morphology by masseteric injection of botulinum toxin type A.
    Gaofeng L, Jun T, Bo P, Bosheng Z, Qian Z, Dongping L.
    J Plast Reconstr Aesthet Surg; 2010 Dec 01; 63(12):2026-31. PubMed ID: 20116356
    [Abstract] [Full Text] [Related]

  • 14. Botulinum toxin type A treatment for contouring of the lower face.
    Park MY, Ahn KY, Jung DS.
    Dermatol Surg; 2003 May 01; 29(5):477-83; discussion 483. PubMed ID: 12752514
    [Abstract] [Full Text] [Related]

  • 15. The medical management of masseteric hypertrophy with botulinum toxin.
    Finn S, Ryan P, Sleeman D.
    J Ir Dent Assoc; 2000 May 01; 46(3):84-6. PubMed ID: 11323940
    [Abstract] [Full Text] [Related]

  • 16. Type A botulinum toxin for the treatment of hypertrophy of the masseter and temporal muscles: an alternative treatment.
    von Lindern JJ, Niederhagen B, Appel T, Bergé S, Reich RH.
    Plast Reconstr Surg; 2001 Feb 01; 107(2):327-32. PubMed ID: 11214045
    [Abstract] [Full Text] [Related]

  • 17. Temporal volume increase after reduction of masseteric hypertrophy utilizing incobotulinumtoxin type A.
    Nikolis A, Enright KM, Rudolph C, Cotofana S.
    J Cosmet Dermatol; 2020 Jun 01; 19(6):1294-1300. PubMed ID: 32338450
    [Abstract] [Full Text] [Related]

  • 18. Treatment of unilateral masseter hypertrophy with botulinum toxin in two cases.
    Işeri M, Işeri PK.
    Kulak Burun Bogaz Ihtis Derg; 2004 Jun 01; 12(3-4):99-102. PubMed ID: 16010109
    [Abstract] [Full Text] [Related]

  • 19. Botulinum toxin type A in the management of masseter muscle hypertrophy.
    Castro WH, Gomez RS, Da Silva Oliveira J, Moura MD, Gomez RS.
    J Oral Maxillofac Surg; 2005 Jan 01; 63(1):20-4. PubMed ID: 15635552
    [Abstract] [Full Text] [Related]

  • 20. The treatment of masseter hypertrophy with botulinum toxin type A.
    Al-Ahmad HT, Al-Qudah MA.
    Saudi Med J; 2006 Mar 01; 27(3):397-400. PubMed ID: 16532107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.